Download: Repurposing human therapies for pachyderm wound healing
In Synedgen’s whitepaper “Repurposing human therapies for pachyderm wound healing”, the company talks about the extent of this problem, as well as what can be done to combat it.
Among other items, the article discusses:
-Repurposing human therapies for pachyderm wound healing
-Understanding potential for animal products from within a human health portfolio
-Taking advantage of the FDAâ€™s minor use/minor species designation to transition into animal health
-Treating chronic foot disease in large mammals
Synedgen’s President and COO Shenda Baker will be presenting a case study on the subject during the second day of the World Animal Health Congress. She will also be participating on a panel concerning advances in pet products in the next decade on the same day. Panel members will address whether the biggest money-makers come from pharmaceuticals, biologics, nutritional products, or somewhere else, and what owners would pay for next generation technologies to ensure their pet’s health.